Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review

Caterina Micolonghi1, Federica Perrone1,2, Marco Fabiani1,3

  • 1Department of Experimental Medicine, Faculty of Medicine and Dentistry, Sapienza University of Rome, 00161 Rome, Italy.

Insights

This review explores minor genes in hereditary cardiomyopathies (CMPs), such as arrhythmogenic cardiomyopathy (ACM), dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM). Understanding these genetic factors improves diagnostic accuracy and treatment for heart conditions.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genomic Medicine

Background:

  • Hereditary cardiomyopathies (CMPs), including arrhythmogenic cardiomyopathy (ACM), dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM), are significant causes of cardiovascular morbidity and mortality.
  • Genetic factors are primary drivers of CMPs, with next-generation sequencing (NGS) identifying numerous causative variants.
  • While core genes are routinely screened, the role of minor genes in CMPs remains less understood.

Purpose of the Study:

  • To review current evidence on the involvement of minor genes in the pathogenesis and prognosis of hereditary cardiomyopathies.
  • To provide a comprehensive overview of the genetic landscape of minor genes implicated in CMPs.
  • To offer guidance for clinical practice and future research directions.

Main Methods:

  • Comprehensive literature review of recent studies on hereditary cardiomyopathies.
  • Analysis of genetic databases (ClinGen, ClinVar) and resources (GeneReviews).
  • Evaluation of diagnostic guidelines and clinical referral data.

Main Results:

  • Minor genes, though less characterized, harbor variants that may contribute to CMP mechanisms and influence patient outcomes.
  • An increasing body of evidence supports the clinical significance of variants in these less-studied genes.
  • Individual assessment based on clinical context is crucial for interpreting the pathogenicity of minor gene variants.

Conclusions:

  • Further research is essential to elucidate the precise roles of minor genes in hereditary cardiomyopathies.
  • Enhanced understanding of these genetic factors will improve diagnostic precision.
  • Future studies will facilitate the development of targeted therapeutic strategies for CMP patients.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
22.0K